Overcoming Barriers to Biologic Therapy in CRSwNP Through Collaborative Evidence-Based Care
Webinar/Online
Thursday, December 18, 2025 at 6:00pm ET - 7:00pm ET
Add this event to your calendar
Posted by Integrity Continuing Education
Info
Topic
Key challenges remain in managing chronic rhinosinusitis with nasal polyps (CRSwNP), including inconsistent use of assessment tools, common questions concerning biologic therapies, and gaps in shared decision-making. Clinicians often struggle with selecting appropriate treatment for individual patients, treatment timing, and communication, while patients report limited understanding of biologics. Through interactive, case-based learning, this program fosters collaboration between allergists and otolaryngologists, aiming to improve treatment consistency, patient satisfaction, and long-term outcomes in CRSwNP care.
Credits Offered
This event offers
1.0 CME credit
to attendees.
Accreditation Info:
ACCME.
Additional Information
TARGET AUDIENCE
This educational activity has been designed to meet the needs of allergists, otolaryngologists/allergists, otolaryngologists, and specialty advanced practice providers involved in the management of patients with CRSwNP.
LEARNING OBJECTIVES
Upon completion of this educational activity, participants should be able to:
- Implement both subjective and objective measures in the evaluation and assessment of patients with CRSwNP
- Select treatments for patients with CRSwNP based on individual patient characteristics and available evidence
- Implement strategies to overcome barriers to the optimal use of biologics in the treatment of patients with CRSwNP
Speakers
Section Chief, Rhinology
Brigham and Women’s Hospital
Harvard Medical School
Boston, Massachusetts
Professor of Medicine
Director of Clinical Research
Division of Allergy/Immunology and Otolaryngology
Northwestern University Feinberg School of Medicine
Chicago, Illinois